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Introduction {#sec1}
============

TRPM8 channels detect a wide range of cold temperatures, spanning from innocuous cooling to noxious cold ([@bib22], [@bib23], [@bib28]). It is also activated by cooling-mimetic compounds, such as menthol and its derivative, WS-12. The basal cold sensitivity of TRPM8 is critical to many physiological processes ranging from cold sensation to core body temperature regulation ([@bib1], [@bib3], [@bib6], [@bib8]), to basal tear secretion ([@bib27]). Furthermore, activation of TRPM8 inhibits inflammatory and neuropathic pain, mediating an analgesic effect ([@bib6], [@bib12], [@bib18], [@bib31]), though it causes cold hypersensitivity in some cases ([@bib3], [@bib5], [@bib12]). TRPM8 has also been implicated in the inhibition of tissue inflammatory responses and inflammatory cytokine release ([@bib2], [@bib33], [@bib40]). Activation of TRPM8, therefore, inhibits both pain and inflammation, which may underlie cold therapy that has been used to relieve pain and inflammation for hundreds of years.

However, TRPM8 was inhibited during inflammation due to the actions of released inflammatory mediators such as bradykinin (BK) and histamine ([@bib16], [@bib30], [@bib47]). Inhibition of TRPM8, therefore, disinhibits the anti-pain and anti-inflammatory effects of TRPM8, contributing to aggravated pain, inflammation, and possibly dry eye diseases ([@bib18], [@bib41], [@bib47]).

BK and histamine act on Gα~q~-coupled receptors. Initially, TRPM8 inhibition induced by BK was attributed to dephosphorylation of TRPM8 by activated protein kinase C (PKC) ([@bib30]). Another appealing possibility is that activated Gα~q~-PLCβ catalyzes hydrolysis of the membrane lipid phosphatidylinositol 4, 5-bisphosphate (PIP~2~), which is essential for TRPM8 activation ([@bib17], [@bib35]), leading to TRPM8 inhibition. Indeed, PIP~2~ hydrolysis-mediated TRPM8 inactivation has been implicated in TRPM8 desensitization and cold adaptation ([@bib4], [@bib35]).

Adding to the complexity, we have found that activated Gα~q~ directly inhibits TRPM8 *in vitro* ([@bib47]). However, it is not yet clear whether direct Gα~q~ gating of TRPM8 also occurs in native sensory neurons and which mechanisms are mainly responsible for TRPM8 inhibition by inflammatory mediators *in vivo*. After all, activated Gα~q~ will inevitably activate downstream PLCβ, triggering the concomitant breakdown of PIP~2~. It is also not known how Gα~q~ directly gates TRPM8 and the relative role of Gα~q~ gating and PIP~2~ signaling in TRPM8 modulation.

In this research, I have found that direct Gα~q~ gating is crucial for regulating the basal cold sensitivity of TRPM8 and is the sole mechanism of TRPM8 inhibition elicited by BK in native sensory neurons without significant involvement of PLCβ-PIP~2~ signaling or Gα~11~ in this process. Importantly, I revealed the Gα~q~ gating mechanism and identified three basic arginine residues on the N-terminal melastatin homology region (MHR) 1--3 in TRPM8 as Gα~q~ gating sites. Mutation of these sites entirely abolished TRPM8 inhibition by activated Gα~q~ and BK and also significantly reduced TRPM8 inhibition by histamine. I further elucidated the mechanism for the lack of a role of PIP~2~ in TRPM8 inhibition by BK, and I found that it is determined by a bidirectional crosstalk in the TRPM8-Gα~q~-B2R complex. Our data also suggest independent and cooperative modulation of TRPM8 by Gα~q~ and PIP~2~.

Results {#sec2}
=======

Gα~q~ Is Crucial for the Cold Sensitivity of TRPM8 in Sensory Neurons {#sec2.1}
---------------------------------------------------------------------

We have previously shown that activated Gα~q~ directly inhibits TRPM8 channels *in vitro* ([@bib47]), but it remains unknown whether this mechanism also occurs to sensory neurons. To discriminate between Gα~q~ gating and PIP~2~ signaling in TRPM8 modulation in sensory neurons, I took advantage of Gα~q~ knockout (KO) mice, in which Gα~11~ remains intact and will take over the activation of downstream PLCβ-PIP~2~ signaling.

Cell-attached patch clamping was used to record TRPM8-mediated firing responses in small-to-medium sensory dorsal root ganglia (DRG) neurons, because the cell-attached mode preserves intracellular modulatory factors, minimizing artificial disruption of intracellular signaling ([@bib21]); furthermore, TRPM8 exhibits run-down in other patch configurations ([@bib17]). [Figure 1](#fig1){ref-type="fig"}A shows that a ramp drop in bath temperatures elicited firing discharges in a DRG neuron at 26.6°C. A second cold ramp evoked similar firing responses with little desensitization. To verify that cold-elicited firing is mediated by TRPM8, DRG neurons were exposed to PBMC, a specific TRPM8 antagonist ([@bib11]), during the second cold ramp. As shown in [Figure 1](#fig1){ref-type="fig"}B, PBMC completely blocked firing induced by the second cold challenge. Furthermore, the same neurons also responded to the specific TRPM8 agonist WS-12 ([Figures 1](#fig1){ref-type="fig"}A and 1B), validating that cold-induced firing is mediated by TRPM8. The effects of PBMC and WS-12 were, therefore, used to identify TRPM8-mediated cold responses in DRG neurons. With this approach, ∼30% of probed cells responded to cold, and ∼68% of these cold-sensitive neurons were TRPM8^+^. TRPM8-independent firing responses were excluded from further analysis.Figure 1Gα~q~ Is Crucial for the Cold Sensitivity of TRPM8^+^ DRG Neurons(A--D) Firing responses evoked by two consecutive cold ramps and WS-12 (1 μM) in wild-type (WT) (A and B) and Gα~q~^−/−^ (C and D) DRG neurons in the absence (A and C) or presence (B and D) of PBMC (50 nM). Arrows indicate cold activation threshold.(E) Histogram distribution of cold activation threshold of DRG neurons from experiments similar to those in (A)--(D). WT, n = 25; Gα~q~^−/−^, n = 24.(F) Bar summary of threshold for cold activation of DRG neurons.(G and H) Summary of total number of firing (G) and average peak amplitude of firing (H) responses evoked during cold application period from the same experiments as described above.(I) Summary of total number of firing responses evoked during capsaicin application (0.5 μM, 10 s).Error bars in all figures represent mean ± SEM. ^∗^p \< 0.05; ^∗∗∗^p \< 0.001; NS, not significant. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

I then performed similar experiments in DRG neurons isolated from Gα~q~-deficient mice. I first validated the ablation of Gα~q~, but not Gα~11~, in Gα~q~-lacking DRG neurons ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Gα~q~-deficient DRG neurons responded to two consecutive cold ramps similarly to wild-type (WT) neurons ([Figure 1](#fig1){ref-type="fig"}C), but they started to fire at a higher temperature threshold ([Figures 1](#fig1){ref-type="fig"}C and 1D). The cold responses were blocked by PBMC, and the same neurons also responded to WS-12, confirming that cold-evoked firing responses are TRPM8 dependent ([Figures 1](#fig1){ref-type="fig"}C and 1D). Overall, deleting Gα~q~ markedly shifted the temperature threshold for TRPM8 activation in DRG neurons toward higher temperature ranges in both low- and high-threshold cold-sensing neurons ([Figure 1](#fig1){ref-type="fig"}E), leading to a significant increase of 3.2°C in the cold activation threshold ([Figure 1](#fig1){ref-type="fig"}F) (WT, 26.16°C ± 0.6°C; Gα~q~^−/−^, 29.37°C ± 0.61°C; p \< 0.001), consistent with the finding of the basal inhibition of TRPM8 channels by endogenous Gα~q~ ([@bib47]). Notably, cold temperatures also induced much more TRPM8-dependent firing events in Gα~q~ KO neurons than in WT neurons ([Figures 1](#fig1){ref-type="fig"}A--1D and 1G), though there was no significant difference in firing amplitude between WT and KO neurons ([Figure 1](#fig1){ref-type="fig"}H). Enhanced TRPM8 responses are not caused by indirect upregulation of TRPM8, because TRPM8 expression was not altered in Gα~q~ KO neurons ([Figure S1](#mmc1){ref-type="supplementary-material"}B). In contrast to cold, firing events induced by capsaicin were not significantly different between WT and Gα~q~ KO neurons ([Figure 1](#fig1){ref-type="fig"}I), suggesting that increased firing responses in Gα~q~-lacking neurons are specific to cold and unlikely to be mediated by indirect effects of Gα~q~ deletion on other action potential transducing channels such as voltage-gated sodium channels.

These experiments demonstrate that Gα~q~ tonically inhibits the basal cold sensitivity of TRPM8 channels in DRG neurons and suggest that Gα~q~ is present in both low- and high-threshold cold-sensing DRG neurons.

Gα~q~ Is Essential for Inhibiting Firing Responses Induced by Bradykinin {#sec2.2}
------------------------------------------------------------------------

To investigate whether Gα~q~ is also crucial for TRPM8 inhibition induced by BK in DRG neurons, cells were stimulated by WS-12, and induced firing activity was monitored with cell-attached recording. Under control conditions, no significant changes in firing were observed in either WT or Gα~q~ KO neurons after vehicle perfusion (1 min) ([Figures 2](#fig2){ref-type="fig"}A, 2D, and 2G). The same procedure was then used to investigate the effect of BK on TRPM8. Of note, the functional BK receptor B2R is co-expressed in 33.3% TRPM8^+^ DRG neurons ([@bib47]) but in 83.9% TRPV1^+^ DRG neurons, indicated by the proportion of neurons in which TRPV1 is sensitized by BK ([@bib46]) (also discussed later). In fact, BK-induced inhibition of TRPM8 was only observed in TRPV1^+^ neurons ([@bib47]). Therefore, to ensure that the recorded neurons express B2R and to preclude the neurons lacking B2R from confounding analysis, I selected TRPM8^+^ DRG neurons exhibiting TRPV1 sensitization and/or TRPM8 inhibition in response to BK as an index of B2R expression. As expected, WS-12-elicited firing responses were significantly inhibited and even completely eliminated by BK in some WT DRG neurons ([Figures 2](#fig2){ref-type="fig"}B and 2G). Furthermore, the response to capsaicin in this neuron was also sensitized by BK ([Figure 2](#fig2){ref-type="fig"}C), confirming functional B2R expression. In contrast, BK did not inhibit TRPM8-triggered firing in Gα~q~-lacking DRG neurons and, in fact, slightly increased firing elicited by WS-12, though it was not statistically significant compared to control ([Figures 2](#fig2){ref-type="fig"}E and 2G). The lack of inhibitory effect was not due to lack of expression of B2R or Gα~11~ or impaired PLCβ signaling in Gα~q~-deficient DRG neurons, because firing responses elicited by capsaicin in the same neurons were sensitized by BK ([Figures 2](#fig2){ref-type="fig"}F and 2H), an event depending on the Gα~q/11~-PLCβ signaling pathway ([@bib20], [@bib46]); furthermore, Gα~11~ is expressed in every DRG neuron ([@bib9]). As complementary evidence, BK also sensitized TRPV1 in Gα~q~ null neurons to a degree similar to that in WT neurons in whole-cell patch clamping ([Figures 2](#fig2){ref-type="fig"}I, 2J, and [7](#fig7){ref-type="fig"}J); moreover, the sensitization was completely prevented by the phospholipase C (PLC) inhibitor U73122, validating the involvement of PLCβ in this process. These data suggest that PLCβ signaling is not impaired in DRG neurons lacking Gα~q~, consistent with the finding that Gα~q~, rather than Gα~11~, plays a major role in TRPM8 inhibition ([@bib14], [@bib47]).Figure 2Gα~q~ Is Essential for BK-Induced Inhibition of TRPM8-Dependent Firing Responses in DRG Neurons(A--C) Representative firing responses elicited by WS-12 (1 μM) or capsaicin (Cap, 0.5 μM) (C) in WT DRG neurons before and after vehicle (A) or BK (1 μM, 1 min) (B and C). (B) and (C) indicate the same neuron.(D--F) Example firing responses evoked by WS-12 or capsaicin (F) in DRG neurons lacking Gα~q~ before and after vehicle (D) or BK (E and F). (E) and (F) indicate the same neuron.(G) Scatterplot of ratio of action potentials (APs) induced by WS-12 after and before BK in experiments similar to those in (A)--(D). ^∗∗^p = 0.00588; NS, p = 0.107.(H) Summary of ratio of firing responses evoked by capsaicin after and before BK from experiments similar to those in (C) and (F).(I) Example currents evoked by capsaicin (100 nM, 5 s) in a Gα~q~ null DRG neuron. The gap indicates BK treatment (1 μM, 1 min).(J) Collective results of sensitization fold caused by BK from experiments similar to those in (I). The sensitization was abolished by U73122 (2.5 μM). The number of experiments is denoted above each bar.All data indicate mean ± SEM. ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001; NS, not significant.

Altogether, these experiments demonstrate that Gα~q~ is crucial for both the basal and BK-induced TRPM8 inhibition in DRG neurons. Neither Gα~11~ nor downstream PLCβ signaling is involved in these processes.

Identification of Gα~q~ Effector Sites on TRPM8 Channels {#sec2.3}
--------------------------------------------------------

Activated Gα~q~ rapidly inhibits TRPM8 through binding to TRPM8 ([@bib47]). Therefore, Gα~q~ binding sites on TRPM8 should constitute critical channel gating sites. To ascertain which terminus of TRPM8 contains functional Gα~q~ binding sites, the GST (glutathione S-transferase)-coupled N or C terminus of TRPM8 was used to pull down different chimeric Gα~q~ proteins in which different functional regions in the distal C terminus of Gα~q~ are replaced by Gα~i~ ([Figure 3](#fig3){ref-type="fig"}A) ([@bib47]). In general, the binding of Gα~q~ to the N terminus is stronger than that to the C terminus of TRPM8 ([Figures 3](#fig3){ref-type="fig"}B and 3C), suggesting that the N terminus of TRPM8 is more critical to Gα~q~ gating. The most potent binding to the N terminus of TRPM8 was found with Gα~qi~, 2Gα~qi~, and 3Gα~qi~ ([Figure 3](#fig3){ref-type="fig"}B), which also exert a potent inhibitory effect on TRPM8 ([@bib47]). Reduced binding to the N terminus was observed with 4Gα~qi~ and 5Gα~qi~ ([Figure 3](#fig3){ref-type="fig"}B), which exhibit a diminished inhibitory effect on TRPM8 due to the replacement of Switch III in Gα~q~ by the equivalent part from Gα~i~ in these chimeras ([Figure 3](#fig3){ref-type="fig"}A) ([@bib47]). The good correlation between the binding of Gα~q~ chimeras to the N terminus and the functional effect on TRPM8 further suggests that the N terminus of TRPM8 contains Gα~q~ gating sites. The binding experiment also supports that the N terminus mainly binds to Switch III in Gα~q~ ([Figure 3](#fig3){ref-type="fig"}A), a major region also responsible for the gating of TRPM8 ([@bib47]), consistent with the suggestion of a critical role of the N-terminal TRPM8 in Gα~q~ gating. In contrast, reduced binding to the C terminus of TRPM8 was observed in 3Gα~qi~ ([Figure 3](#fig3){ref-type="fig"}C), in which the α3 helix downstream of Switch III in Gα~q~ is replaced ([Figure 3](#fig3){ref-type="fig"}A), suggesting that the C terminus of TRPM8 primarily binds to the α3 helix, a region also responsible for binding to PLCβ ([Figure 3](#fig3){ref-type="fig"}A) ([@bib38], [@bib39]).Figure 3Delineation of Gα~q~Binding Regions in TRPM8(A) Schematic diagram shows different Gα~qi~ chimeras and regions binding to the N- and C-terminus of TRPM8, and PLCβ.(B and C) GST-coupled N terminus (B) and C terminus (C) of TRPM8 bind to different Gα~q~ chimeras in pull-down assays. IP, immunoprecipitation.(D) Schematic diagram shows different N-terminal fragments coupled to GST.(E) The binding of Gα~q~ Q209L to different GST-coupled N-terminal fragments of TRPM8. Total cell lysate (TCL) denotes Gα~q~ expression.(F) The binding of Gα~q~ Q209L to different C-terminal fragments coupled to GST (top) in a GST pull-down assay (bottom).(G) Schematic diagram depicts the relationship of Gα~q~ binding regions (N7, N8, and TRP) and other domains.

To further delineate Gα~q~ binding regions in the N terminus, a series of different N-terminal fragments coupled to the GST tag were constructed for Gα~q~ pull-down assay ([Figure 3](#fig3){ref-type="fig"}D). With this approach, two small regions, N7 (F245-E398) and N8 (R451-N606), were found to be responsible for the binding of Gα~q~ to the N terminus ([Figures 3](#fig3){ref-type="fig"}E and 3G). These two short regions, therefore, likely contain the functional Gα~q~ effector sites. Using a similar approach, I have also found that the main Gα~q~ binding region in the C terminus is located in the proximal C terminus of TRPM8 ([Figure 3](#fig3){ref-type="fig"}F), a region also containing the TRP domain critical to TRPM8 gating and modulation ([Figure 3](#fig3){ref-type="fig"}G). Taken together, Gα~q~ binds to N7 and N8 in the N terminus and also to the proximal C terminus of TRPM8, although N7 and N8 are more likely to be the functional Gα~q~ gating regions ([Figure 3](#fig3){ref-type="fig"}G). Reciprocally, the N and C termini of TRPM8 mainly bind to Switch III and the α3 helix in Gα~q~, respectively ([Figure 3](#fig3){ref-type="fig"}A).

Activated Gα~q~ gates TRPM8 through Switch III ([@bib47]), a region undergoing major conformational changes upon exchange of guanosine triphosphate (GTP) for guanosine diphosphate (GDP) on Gα~q~ during Gα~q~ activation ([@bib13], [@bib39]), consistent with the structural requirement for effector interaction. Notably, Switch III contains a cluster of acidic residues. Surface charge modeling of Gα~q~ also revealed that Switch III is negatively charged ([Figure 4](#fig4){ref-type="fig"}A). Therefore, I hypothesized that the Gα~q~ effector sites on TRPM8 are positive, allowing for electrostatic interaction with negative Switch III in Gα~q~. Interestingly, a cluster of basic arginine and lysine residues were found on N7, with a distribution pattern similar to those of acidic residues on Switch III in Gα~q~ ([Figure 4](#fig4){ref-type="fig"}A). These basic residues were then neutralized by mutation to glutamine.Figure 4Identification of Gα~q~ Effector Sites on TRPM8(A) Molecular surface charge representation of Gα~q~. Key domains and distance are shown. Underneath is the alignment of charged residues (in red) in Switch III of Gα~q~ and N7-TRPM8.(B) Example inward and outward whole-cell currents elicited by menthol (200 μM, 5 s) at −60 mV and 60 mV, respectively, in HEK293 cells expressing TRPM8 and mutants as indicated.(C) Summary of TRPM8 peak currents from similar experiments to those in B (n = 19--28).(D) Summary of the effect of 3Gα~qi~ on the peak currents of TRPM8 and R470Q elicited by menthol (n = 22--35).(E) Averaged current-voltage (I-V) traces of TRPM8 and R470Q with or without 3Gα~qi~ co-expression (n = 16--27).(F) Binding of Gα~q~ Q209L to GST-N7 and R470Q mutant in a GST pull-down assay.(G) On the left is a diagram showing different truncations of N8-TRPM8. On the right, the binding of truncated N8 fragments to Gα~q~ Q209L is indicated.(H) Summary of inward and outward currents of different TRPM8 mutants elicited by menthol.(I) GST pull-down assay shows the binding of Gα~q~ Q209L to GST-N8 and mutants as indicated.(J) Summary of currents of R364Q-R368Q mutant with or without co-expression of 3Gα~qi~. The number of experiments is indicated above each bar.(K) Average I-V relationship of R364Q-R368Q mutant with (n = 27) or without (n = 20) the co-presence of 3Gα~qi~.All error bars represent mean ± SEM. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001; NS, not significant.

In principle, the mutation of Gα~q~ effector sites on TRPM8 should disrupt Gα~q~ binding, abolish the inhibitory effect of Gα~q~, and potentiate the function of TRPM8 channels. Indeed, I found that neutralizing R470 markedly enhanced TRPM8 inward and outward currents evoked by menthol, while mutation of other nearby basic residues either reduced TRPM8 currents or had no significant effect ([Figures 4](#fig4){ref-type="fig"}B and 4C). Moreover, R470Q mutant abolished the inhibition of outward current and reduced the inhibition of inward current caused by 3Gα~qi~, an activated Gα~q~ chimera containing Q209L mutation, while downstream signaling to PLCβ was selectively ablated ([Figure 4](#fig4){ref-type="fig"}D) ([@bib47]), although 3Gα~qi~ still significantly inhibited the inward current of R470Q ([Figure 4](#fig4){ref-type="fig"}D). Depolarization-induced outward currents in R470Q were also much larger than those in WT TRPM8 but were still inhibited by 3Gα~qi~, as seen in the WT channel ([Figure 4](#fig4){ref-type="fig"}E). Notably, mutating R470 completely eliminated the binding of activated Gα~q~ to the N7 fragment ([Figure 4](#fig4){ref-type="fig"}F), demonstrating that R470 is crucial to the binding between Gα~q~ and N7. Taken together, these results suggest that R470 is a critical Gα~q~ effector site on TRPM8. However, the incomplete abrogation of Gα~q~-elicited inhibition of TRPM8 by R470Q mutation suggests the presence of other unidentified Gα~q~ effector sites, likely on N8 (discussed later).

There are no obvious clusters of positive residues on N8. To narrow down the Gα~q~ binding region in N8, a progressive truncation of N8 coupled to GST was generated and used to pull down Gα~q~ ([Figure 4](#fig4){ref-type="fig"}G). A prominent reduction in Gα~q~ binding was observed when the distal 36 amino acids were truncated from the C terminus of N8 ([Figure 4](#fig4){ref-type="fig"}G), suggesting that these 36 amino acids contain Gα~q~ binding sites. Meanwhile, basic residues in N8 were individually neutralized to glutamine. Currents mediated by these mutated channels were then monitored using whole-cell patch clamping. I found that neutralization of two individual arginine residues (R364Q and R368Q) on N8 both significantly enhanced TRPM8 currents ([Figure 4](#fig4){ref-type="fig"}H). TRPM8 currents were further increased after mutating these two sites in combination (R364Q-R368Q) ([Figure 4](#fig4){ref-type="fig"}H). However, all other mutants were without significant effect. Coincidently, R364 and R368 fall within the distal 36 amino acids in N8 that are also critical to Gα~q~ binding ([Figure 4](#fig4){ref-type="fig"}G). As anticipated, neutralization of these two sites in N8 was also sufficient to disrupt the binding between N8 and Gα~q~ ([Figure 4](#fig4){ref-type="fig"}I), suggesting that these two sites are also Gα~q~ effector sites. Consistent with this idea, the inhibitory effects of 3Gα~qi~ on the inward and outward currents of TRPM8 evoked by menthol were abolished in the double mutant (R364Q-R368Q) ([Figure 4](#fig4){ref-type="fig"}J). However, voltage gating of R364Q-R368Q was still inhibited by 3Gα~qi~ ([Figure 4](#fig4){ref-type="fig"}K).

Altogether, Gα~q~ binds to two small regions in the N terminus of TRPM8 (N7 and N8), and three positively charged arginine residues (R364, R368, and R470) within these regions function as Gα~q~ effector sites. These experiments also support the notion that gating of TRPM8 by menthol and voltage is separable through independent mechanisms, though they are allosteric during TRPM8 gating.

Gα~q~ Effector Sites Are Responsible for Gα~q~ Gating of TRPM8 {#sec2.4}
--------------------------------------------------------------

I next mutated all three basic arginine residues on TRPM8 to glutamine and named the mutant TRPM8-TM (triple mutant). As expected, TRPM8-TM exhibited much larger currents than the WT channel and completely abolished the inhibitory effects of 3Gα~qi~ on TRPM8 currents elicited by menthol ([Figures 5](#fig5){ref-type="fig"}A and 5B). The sensitivity of TRPM8-TM to menthol was also dramatically increased, leading to a marked leftward shift in dose-response curve compared to that of WT TRPM8 (WT, EC~50~ = 148.8 μM ± 8.1 μM; TM, EC~50~ = 40.6 μM ± 5.3 μM) ([Figure 5](#fig5){ref-type="fig"}C). However, this marked leftward shift was not observed in mouse embryonic fibroblast (MEF) cells lacking endogenous Gα~q/11~ (TRPM8 in Gα~q/11~^−/−^, EC~50~ = 75.1 μM ± 2.8 μM; TM in Gα~q/11~^−/−^, EC~50~ = 61.4 μM ± 5.0 μM), supporting the idea that increased sensitivity of TRPM8-TM is due to relief of basal inhibition from endogenous Gα~q/11~ and not caused by indirect alterations to the intrinsic biophysical properties of the channel. These data are also consistent with the basal inhibition of TRPM8 by endogenous Gα~q~ in DRG neurons ([Figures 1](#fig1){ref-type="fig"}C--1G). Notably, TRPM8-TM also entirely abolished the inhibition of 3Gα~qi~ on TRPM8 outward currents evoked by a depolarization voltage ramp ([Figure 5](#fig5){ref-type="fig"}D). A further detailed analysis of voltage gating of TRPM8 through applying a series of depolarization voltage steps revealed that TRPM8-TM shifted the voltage gating of TRPM8 toward negative potentials close to resting membrane potential, resulting in a markedly reduced V~1/2~ (WT, V~1/2~ = 116.0 mV ± 11.0 mV; TM, V~1/2~ = 66.5 mV ± 5.9 mV) ([Figures 5](#fig5){ref-type="fig"}E--5G). It also shows that TRPM8-TM abolished the inhibitory effect of activated 3Gα~qi~ on V~1/2~ observed in the WT channels ([Figure 5](#fig5){ref-type="fig"}G) ([@bib47]).Figure 5Gα~q~ Gates TRPM8 through Three Arginine Residues on TRPM8(A) Representative inward and outward currents of TRPM8 and TRPM8-TM activated by menthol (200 μM, 5 s).(B) Summary of currents of TRPM8 and TRPM8-TM with or without 3Gα~qi~ from experiments similar to those in (A). Data are mean ± SEM. ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001.(C) Dose-response relationship of TRPM8 and TRPM8-TM expressed in HEK293 and Gα~q/11~^−/−^ MEF cells in response to menthol. Curves are fitted with the Hill equation. TRPM8 (♦), EC~50~ = 148.8 μM ± 8.1 μM; TRPM8-TM (▲), EC~50~ = 40.6 μM ± 5.3 μM; TRPM8 in Gα~q/11~^−/−^ MEF (□), EC~50~ = 75.1 μM ± 2.8 μM; TM in Gα~q/11~^−/−^ (△), EC~50~ = 61.4 μM ± 5.0 μM). n = 7--15.(D) Average I-V relationship of TRPM8-TM with (pink, n = 13) or without (black, n = 14) 3Gα~qi~.(E) Example currents of TRPM8 and TRPM8-TM evoked by voltage steps from −120 mV up to 200 mV in 20-mV increments. Maximal current was evoked at 140 mV for TRPM8-TM.(F) Normalized conductance (G)-voltage relationship from the cells in (E) fitted with the Boltzmann equation, giving rise to V~1/2~ and slope factor as follows: TRPM8, 103.5 mV and 36.2 mV; TRPM8-TM, 62.0 mV and 36.3 mV.(G) Collective results of V~1/2~ from experiments similar to those in (E) and (F). The number of experiments is shown above each bar.(H) Side stereoview of a ribbon representation of the TRPM8 structure (6BPQ).(I) Side stereoview of central cavity formed by the N terminus of two opposite TRPM8 subunits. Distance measurements between domains and residues are indicated.Error bars represent mean ± SEM. ^∗∗^p \< 0.01; NS, not significant. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Altogether, TRPM8-TM completely abolished the inhibitory effects of 3Gα~qi~ on TRPM8 activation triggered by both menthol and voltage, demonstrating that three arginine residues (R364, R368, and R470) in the N terminus of TRPM8 are Gα~q~ effector sites responsible for the Gα~q~ gating of TRPM8.

In accordance with the recently revealed TRPM8 structure ([@bib43]), R364 and R368 are located near the bottom stack layer of the cytoplasmic domain (CD) of TRPM8, sitting at a turning loop between two helixes in MHR1-2 ([Figure 5](#fig5){ref-type="fig"}H). R470 also sits at a loop between two helixes (HTH3a and HTH3b) in the MHR3 domain. Three arginine residues constitute a contiguous plane lining a cytoplasmic cavity formed by the CD of TRPM8 ([Figure 5](#fig5){ref-type="fig"}I). Of note, the C-terminal Gα~q~ binding TRP domain and the bottom S6 from the pore domain form the dome of the cytoplasmic cavity. The height of the cavity measured from the bottom of S6 to R368 is 83 Å. The distance of R470 from two opposite subunits is 68 Å, and the distance of two opposite R368 residues is 82 Å ([Figure 5](#fig5){ref-type="fig"}I). Therefore, the size of the cavity is, in principle, sufficient to accommodate Gα~q~ with a dimension of 43 Å × 61 Å ([Figure 4](#fig4){ref-type="fig"}A). In this case, the top of Gα~q~ would be close to the TRP domain and the intracellular mouth of the channel pore. Conformational changes in Gα~q~ upon activation may be transduced to the TRP domain and the pore domain, resulting in the allosteric gating of TRPM8.

Gα~q~ Gating Is Crucial for TRPM8 Inhibition by Inflammatory Mediators {#sec2.5}
----------------------------------------------------------------------

The inflammatory mediators BK and histamine inhibit TRPM8 through binding, respectively, to B2R and H1R, two Gα~q~-coupled G-protein-coupled receptors (GPCRs). Both activated Gα~q~ and concomitant PIP~2~ hydrolysis cause TRPM8 inhibition. The identified TRPM8-TM selectively deficient for Gα~q~ gating but without impairment in PLCβ signaling and PIP~2~ sensitivity (discussed later) will be an excellent tool for determination of the relative role of direct Gα~q~ gating and PIP~2~ signaling in TRPM8 inhibition during inflammatory signaling.

TRPM8 undergoes run-down in the whole-cell configuration, even under Ca^2+^-free conditions ([Figure S3](#mmc1){ref-type="supplementary-material"}), likely due to the breakdown of intracellular PIP~2~ and/or polyphosphate ([@bib17], [@bib45]). Furthermore, intracellular dialysis under the whole-cell configuration may disrupt Gα~q~ coupling and GPCR signaling. To avoid these artificial effects and to minimize the intervention of whole-cell dialysis in intracellular signaling, cells were briefly pretreated with inflammatory mediators (1 min), allowing for intact completion of intracellular signaling before entering the whole-cell configuration for monitoring TRPM8 currents. In HEK293 cells co-expressing TRPM8 and B2R, a short pretreatment with BK elicited a robust inhibition of the inward and outward currents of TRPM8 ([Figures 6](#fig6){ref-type="fig"}A and 6B), consistent with the previous findings ([@bib47]). However, the potent inhibition was completely abolished in TRPM8-TM ([Figures 6](#fig6){ref-type="fig"}A and 6B). Similarly, TRPM8-TM also completely abrogated BK-elicited inhibition of voltage gating of TRPM8 ([Figure 6](#fig6){ref-type="fig"}C). These results suggest that BK-induced TRPM8 inhibition is solely due to direct Gα~q~ gating, consistent with the aforementioned finding in sensory DRG neurons lacking Gα~q~ ([Figures 2](#fig2){ref-type="fig"}D--2G). This conclusion is also supported by the previous pharmacological evidence showing that inhibition of PLCβ by U73122 had no effect on BK-induced TRPM8 inhibition ([@bib47]), arguing against a possible role for PIP~2~ hydrolysis in the functional coupling between B2R and TRPM8.Figure 6Gα~q~ Gating Sites Are Essential for TRPM8 Inhibition by Inflammatory Mediators(A) Example inward and outward currents elicited by menthol (200 μM, 5 s) in HEK293 cells co-expressing B2R and TRPM8 or TRPM8-TM without or with BK pretreatment (1 μM, 1 min, red).(B) Summary of results similar to those in (A).(C) Average I-V relationship of TRPM8 and TRPM8-TM with or without BK treatment (n = 7--13) from experiments similar to those in (A).(D) Findings from experiments similar to those in (A) but from cells co-expressing H1R. Some cells were pretreated with histamine (His, 10 μM, 1 min, red) or together with U73122 (2.5 μM, blue).(E) Summary of results similar to those in (D).(F) Average I-V relationship of TRPM8 and TRPM8-TM with or without histamine and U73122 treatment (n = 6--16) from experiments similar to those in (D).All data indicate mean ± SEM. ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001; NS, not significant. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Potent inhibition of TRPM8 was also observed in cells co-expressing TRPM8 and H1R upon stimulation with histamine ([Figure 6](#fig6){ref-type="fig"}D). In this case, 93.5% of the peak inward current and 41% of the outward current of TRPM8 were inhibited by histamine, in agreement with the previous results ([@bib47]). Similar to BK treatment, TRPM8-TM abolished inhibition of outward current caused by histamine and significantly reduced histamine-induced inhibition of inward current, though histamine still inhibited 43% of the inward current of TRPM8-TM ([Figures 6](#fig6){ref-type="fig"}D and 6E). The remaining inhibition is likely contributed by PIP~2~ hydrolysis due to actions of activated PLCβ. Indeed, the previous pharmacological experiments showed that inhibition of PLCβ by U73122 partially alleviated TRPM8 inhibition by histamine, though it had no effect on BK-induced TRPM8 inhibition ([@bib47]). To further corroborate this idea, cells expressing TRPM8-TM lacking Gα~q~ gating were also pretreated with U73122 for simultaneous prevention of PIP~2~ signaling. As expected, the inhibitory effect of histamine was completely abolished under this condition ([Figures 6](#fig6){ref-type="fig"}D and 6E).

Similar findings were also observed when TRPM8 was activated by membrane voltage. [Figure 6](#fig6){ref-type="fig"}F shows that inhibition of depolarization-induced outward current by histamine was completely abolished only by TRPM8-TM together with U73122 pretreatment, not by either alone. These data conclusively demonstrate that both direct Gα~q~ gating and downstream PIP~2~ hydrolysis contribute to histamine-evoked TRPM8 inhibition, with Gα~q~ gating playing a primary role (∼57%), and the involvement of other mechanisms is unlikely.

Taken together, direct Gα~q~ gating of TRPM8 channels is the sole mechanism for BK-induced inhibition of TRPM8, without a significant role for PIP~2~ hydrolysis. However, both Gα~q~ gating and PIP~2~ signaling contribute to histamine-triggered TRPM8 inhibition.

TRPM8 Is Insensitive to PIP~2~ Depletion in the Presence of B2R {#sec2.6}
---------------------------------------------------------------

Both B2R and H1R are Gα~q~-coupled GCPRs. How can PIP~2~ signaling play a role in the modulation of TRPM8 initiated by H1R, but not by B2R, though both receptors use Gα~q~ gating for modulation of TRPM8? To elucidate this question, I used the inducible PIP~2~ depletion system in which 5-phosphatase (5-ptase) coupled to FK506-binding protein 12 (FKBP12) is rapidly recruited to the membrane through dimerization with a membrane-targeted fragment of mammalian target of rapamycin (mTOR) by rapamycin, resulting in the depletion of membrane PIP~2~ ([@bib37]). I first confirmed that the addition of rapamycin elicited a rapid reduction of membrane PIP~2~ with this system, as indicated by a prompt translocation of co-expressed Tubby-R332H-YFP, a reporter of membrane PIP~2~ level, to the cytoplasm ([Figures 7](#fig7){ref-type="fig"}A and 7B). I then investigated the effect of PIP~2~ depletion on TRPM8 currents in HEK293 cells expressing the inducible PIP~2~-depleting system. As anticipated, TRPM8 currents were markedly inhibited by rapamycin ([Figures 7](#fig7){ref-type="fig"}C and 7D). A similar extent of inhibition by rapamycin was also observed with TRPM8-TM, suggesting that mutating Gα~q~ gating sites does not affect the sensitivity of TRPM8 to PIP~2~. However, strikingly, depletion of PIP~2~ with rapamycin ceased to inhibit either TRPM8 or TRPM8-TM when B2R was co-expressed ([Figures 7](#fig7){ref-type="fig"}C and 7D). Co-expressed B2R also significantly inhibited the basal currents of TRPM8 and TRPM8-TM, likely due to reduced sensitivity of the channels to basal membrane PIP~2~. In contrast, co-expression of H1R did not affect the responses of TRPM8 to PIP~2~ depletion ([Figure S4](#mmc1){ref-type="supplementary-material"}), suggesting that B2R, but not H1R, alters the sensitivity of TRPM8 channels to PIP~2~. Consistent with this idea, TRPM8 binds to B2R, but not to H1R ([Figure 7](#fig7){ref-type="fig"}E). These results suggest that the binding of B2R to TRPM8 influences the PIP~2~ sensitivity of TRPM8 channels, leading to lack of response of TRPM8 to PIP~2~ depletion. These data also confirm the finding that direct Gα~q~ gating is the sole mechanism of TRPM8 inhibition by BK, while histamine-induced TRPM8 inhibition involves both Gα~q~ gating and PIP~2~ signaling.Figure 7TRPM8 Is Insensitive to PIP~2~ Depletion in the Presence of B2R(A) Translocation of Tubby-R332H-cYFP induced by rapamycin (1 μM) in HEK293 cells co-expressing mRFP-FKBP-5-ptase domain and PM-FRB-CFP. Scale bars, 10 μM.(B) Real-time quantification of membrane fluorescence (F~PM~) relative to cytosol fluorescence (F~Cytosol~) in the top left cell from (A).(C) Example of whole-cell inward and outward currents elicited by menthol in HEK293 cells co-expressing mRFP-FKBP-5-ptase and PM-FRB-CFP together with either TRPM8 and B2R or TRPM8-TM and B2R. Red traces indicate cells pretreated with rapamycin (Rapa, 1 μM, 1 min).(D) Collective results from experiments similar to those in (C).(E) Binding of TRPM8 to B2R, but not to H1R, in a nickel-beads (Ni-NTA) pull-down assay performed on HEK293 cell lysate expressing the proteins as indicated.(F) Binding between PLCβ-his (6×) and Gα~q~ Q209L is reduced in the presence of TRPM8 in a nickel beads pull-down assay. Lane 1 indicates total cell lysate (TCL).(G) Translocation of Tubby-R332H-cYFP at different time points after the addition of BK (1 μM) in HEK293 cells co-expressing B2R or together with TRPM8 or C-terminal deleted (TRPM8-CD). Scale bars, 10 μM. On the right, real-time quantification of membrane Tubby fluorescence is indicated relative to cytosol fluorescence from the cells in (G).(H) Summary of results similar to those in (G).(I) Example inward currents evoked by capsaicin (Cap, 100 nM, 5 s) in HEK293 cells expressing TRPV1 and B2R or together with TRPM8 before and after BK treatment (1 μM, red). TRPM8 co-expression is indicated by currents elicited by menthol (Men, 200 μM).(J) Summary of TRPV1 sensitization fold induced by BK in experiments similar to those in (I). BK-induced sensitization of TRPV1 was also significantly different between TRPM8^+^ and TRPM8^−^ DRG neurons indicated by responses to menthol.All error bars represent mean ± SEM. ^∗∗^p \< 0.01; ^∗∗^p \< 0.05; ^∗∗∗^p \< 0.001; NS, not significant. See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Gα~q~ engages and activates PLCβ through extensive contacts with the catalytic domain in PLCβ via Switch regions and the α3 helix in Gα~q~ ([@bib39]), the same regions also binding to the N and C termini of TRPM8 ([Figure 3](#fig3){ref-type="fig"}A). Notably, a cluster of acidic residues in Switch III of Gα~q~ crucial for TRPM8 gating was also found critical to PLCβ binding and activation ([@bib38]), raising the possibility that TRPM8 competes with PLCβ for Gα~q~ binding, thereby interfering with Gα~q~-PLCβ interaction and coupling. Indeed, TRPM8 prevented the binding of Gα~q~ to PLCβ in a nickel-beads pull-down assay ([Figure 7](#fig7){ref-type="fig"}F). Consistently, co-expression of TRPM8 also significantly reduced Gα~q~-PLCβ signaling activated by BK, as indicated by a significantly smaller reduction of membrane Tubby-R332H-YFP fluorescence and, hence, less PIP~2~ hydrolysis ([Figures 7](#fig7){ref-type="fig"}G and 7H). The reduced PIP~2~ hydrolysis was, however, not observed in C-terminus-deleted TRPM8 ([Figures 7](#fig7){ref-type="fig"}G and 7H), supporting a role for the C terminus of TRPM8 in the intervention of Gα~q~-PLCβ signaling. Functionally, co-expression of TRPM8 significantly reduced TRPV1 sensitization in both transfected HEK293 cells and DRG neurons induced by BK ([Figures 7](#fig7){ref-type="fig"}I and 7J), an event depending on Gα~q~-PLCβ-PKC signaling ([@bib46]), further demonstrating that TRPM8 prevents Gα~q~-PLC signaling.

In summary, B2R-Gα~q~ and TRPM8 crosstalk, forming a bidirectional signaling complex. During Gα~q~ gating of TRPM8, TRPM8 binding also reciprocally interferes with Gα~q~ binding and signaling to PLCβ and PIP~2~. Concomitant B2R binding further renders TRPM8 insensitive to PIP~2~. The crosstalk in the TRPM8-Gα~q~-B2R signaling complex therefore fosters an outcome that direct Gα~q~ gating---rather than PIP~2~ signaling---is a sole mechanism for TRPM8 inhibition triggered by BK during inflammation.

Discussion {#sec3}
==========

In this study, I have investigated the gating mechanisms of TRPM8 by Gα~q~ and its role in the modulation of the cold sensitivity of TRPM8 during inflammatory signaling. I found that Gα~q~ constitutively binds to and gates TRPM8, inhibiting the basal cold sensitivity of TRPM8 in sensory DRG neurons under resting conditions. Direct Gα~q~ gating is also responsible for TRPM8 inhibition elicited by BK and histamine under inflammatory conditions.

I further elucidated the mechanism of lack of a role for PIP~2~ in the modulation of TRPM8 by BK. Surprisingly, B2R binds to TRPM8, rendering the channel insensitive to PIP~2~ depletion. Meanwhile, TRPM8-Gα~q~ binding interferes with Gα~q~-PLCβ binding and signaling, resulting in diminished sensitization of TRPV1. B2R-Gα~q~ and TRPM8, therefore, form a bidirectional signaling complex: on the one hand, Gα~q~ and B2R engage TRPM8, leading to direct Gα~q~ gating and diminished PIP~2~ sensitivity of TRPM8, respectively; on the other hand, TRPM8 binding reciprocally prevents Gα~q~-PLCβ binding and signaling, leading to reduced PIP~2~ hydrolysis. The bidirectional signaling crosstalk in the B2R-Gα~q~-TRPM8 complex, therefore, collectively determines direct Gα~q~ gating as a sole means to inhibit TRPM8 by BK. Furthermore, inhibition of sensitization of TRPV1 by co-expressed TRPM8 suggests that a non-channel-function-dependent mechanism also contributes to the analgesic effect of TRPM8. In contrast to B2R, H1R neither binds to TRPM8 nor influences the PIP~2~ sensitivity of TRPM8, consistent with the finding that PLCβ-PIP~2~ signaling plays a role in histamine-evoked TRPM8 inhibition. These results suggest that the PIP~2~ sensitivity of TRPM8 varies across DRG neurons influenced by co-expressed B2R.

I also revealed the molecular details of TRPM8-Gα~q~ interaction and the functions of different binding regions. The present results support the hypothesis that the N terminus of TRPM8 is crucial to Gα~q~ gating of TRPM8 through binding to Switch III in Gα~q~, while the proximal C terminus interferes with Gα~q~-PLCβ-PIP~2~ signaling through binding to the α3 helix in Gα~q~ ([Figure 3](#fig3){ref-type="fig"}A). The proximal C terminus contains the TRP domain that is critical to the binding and sensitivity of TRPM8 to PIP~2~ ([@bib35]). Gα~q~ binding to the TRP domain may, thus, also influence TRPM8-PIP~2~ binding and the resultant TRPM8 sensitivity to PIP~2~, in addition to diminished PLCβ-PIP~2~ signaling. It is, therefore, likely that Gα~q~ gating and PIP~2~ signaling also crosstalk and cooperate to modulate TRPM8, in addition to their separate and independent roles in the modulation of TRPM8.

Apart from BK and histamine, my previous research suggests that activation of two other Gα~q~-coupled GPCRs--- the muscarinic receptor M1R and the chloroquine receptor MrgprA3---also inhibit TRPM8 through direct Gα~q~ gating ([@bib14], [@bib36]). Interestingly, pharmacological inhibition of PLCβ with U73122 did not exert any effect on TRPM8 inhibition induced by the activation of either of these two GPCRs in a manner similar to that of B2R, suggesting that direct Gα~q~ gating, but not PLCβ-PIP~2~ signaling, is involved in the functional coupling of TRPM8 to both M1R and MrgprA3. Direct Gα~q~ gating may be a primary mechanism underlying TRPM8 modulation by the broad family of Gα~q~-coupled GPCRs.

This study also provided important insights into the mechanisms of Gα~q~ gating of TRPM8 channels. I found that Gα~q~ gates TRPM8 through electrostatic interactions with three basic arginine residues on the N-terminal MHR1--3 of TRPM8. Neutralization of these residues abrogated Gα~q~ binding and its inhibitory effect on TRPM8. The mutation also dramatically enhanced TRPM8 sensitivity and shifted voltage gating close to resting membrane potential, explaining the enhanced cold sensitivity and cold-evoked firing response in DRG neurons lacking Gα~q~. These unveiled Gα~q~ gating sites provide insights into the general gating mechanisms of TRPM8 channels and will advance our understanding of TRPM8 modulation in physiology and diseases. They also suggest a critical role for the MHR domain in the gating of TRPM8 and, potentially, other members of the TRPM family.

How does Gα~q~ gate TRPM8 channels? Our results suggest that R470 and the TRP domain in TRPM8 contact with Switch III and the α3 helix in Gα~q~, respectively ([Figure 3](#fig3){ref-type="fig"}A). This notion is further supported by structural measurements showing that the distance between R470 and the TRP domain (∼36 Å) matches the length of the α3 helix of Gα~q~ (∼30 Å) ([Figures 4](#fig4){ref-type="fig"}A and [5](#fig5){ref-type="fig"}I). Structural modeling of TRPM8-Gα~q~ interaction also suggests that R470 is close to E245 on Gα~q~ and that the top of the α3 helix is close to the bottom of the TRP domain (\<10 Å) ([Figure S2](#mmc1){ref-type="supplementary-material"}). However, R364 and R368 near the bottom of the cavity are far from R470 (∼47 Å) ([Figure 5](#fig5){ref-type="fig"}I). Thus, it seems impracticable that Switch III binds simultaneously to both R470 and R364-R368. However, structural modeling suggests that R364-R368 are close to the helical domain of Gα~q~ ([Figure S2](#mmc1){ref-type="supplementary-material"}), which also exhibits rich negative charges ([Figure 4](#fig4){ref-type="fig"}A), allowing for electrostatic interaction. This interaction may be responsible for the residual binding between the N terminus of TRPM8 and 5Gα~qi~ ([Figure 3](#fig3){ref-type="fig"}B). Overall, Gα~q~ is likely tethered to the cytoplasmic cavity of TRPM8 through interactions with the top TRP domain, lateral R470, and bottom R364-R368 in the cytoplasmic cavity via the α3 helix, Switch III, and the helical domain, respectively ([Figure S2](#mmc1){ref-type="supplementary-material"}). These interactions likely impede structural coupling between different TRPM8 domains, leading to allosteric inhibition of TRPM8 gating. Another prominent feature of the model is that the top of Gα~q~ is close to S6 in addition to the TRP domain of TRPM8. Conformation changes during Gα~q~ activation may, thus, allow Gα~q~ to interact with both the TRP and pore domains, which are critical for integrating allosteric gating signals from cold, cooling agonists, voltage, and PIP~2~ ([@bib44]), mediating the allosteric gating effects of Gα~q~. As Switch III in Gα~q~ is one of the regions undergoing major conformational changes upon Gα~q~ activation and accounts for the majority of binding to TRPM8, while little structural changes occurs to the α3 helix and the helical domain, it is likely that R470 acts as a major Gα~q~ gating site, while R364-R368 function as ancillary tethering sites assisting in Gα~q~ gating. However, the exact mechanisms of TRPM8 gating by Gα~q~ await future determination of the structure of the TRPM8-Gα~q~ complex.

TRPM8 has been implicated in a plethora of pathological conditions and diseases, including pain ([@bib3], [@bib5], [@bib6], [@bib12], [@bib18], [@bib31]), inflammation ([@bib2], [@bib33], [@bib40]), itch ([@bib26]), thermoregulation and energy metabolism ([@bib15], [@bib34]), cancer ([@bib42]), dry eye diseases ([@bib41]), and airway diseases ([@bib19]). TRPM8 has thus become an attractive therapeutic target for treating these conditions and diseases. Potent inhibition of TRPM8 by Gα~q~-coupled GPCRs provides additional therapeutic possibilities for alleviating these diseases and conditions, for example, through existing GPCR agonists or antagonists for modulating TRPM8 activities in affected tissues and organs. Furthermore, in terms of the marked impact of the Gα~q~ effector sites on TRPM8 gating, Gα~q~ gating sites will constitute excellent targets for high-fidelity drug discovery for effective manipulation of TRPM8 function.

Altogether, the discovery of a prominent gating mechanism of TRPM8 by Gα~q~ and its application to inflammation in this research will advance the understanding of the role of TRPM8 in physiology and diseases and provide the basis and guidance for developing intervention strategies for combating TRPM8-associated diseases.

Star★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Mouse monoclonal anti-HA.11CovanceCat\# MMS-101R-1000; RRID:[AB_291262](nif-antibody:AB_291262){#intref0010}Mouse monoclonal anti-β-TubulinSigma-AldrichCat\# T4026; RRID:[AB_477577](nif-antibody:AB_477577){#intref0015}Rabbit polyclonal anti-GaqSanta CruzCat\# sc-393; RRID:[AB_631536](nif-antibody:AB_631536){#intref0020}Rabbit polyclonal anti-Ga11Santa CruzCat\# sc-394; RRID:[AB_2111195](nif-antibody:AB_2111195){#intref0025}Rabbit polyclonal anti-PLCβSanta CruzCat\# sc-9050; RRID:[AB_2165496](nif-antibody:AB_2165496){#intref0030}Rabbit polyclonal anti-TRPM8Alomone labsCat\# ACC-049; RRID:[AB_2040254](nif-antibody:AB_2040254){#intref0035}Anti-GST HRP conjugatedGE healthcareCat\# RPN1236; RRID:[AB_771429](nif-antibody:AB_771429){#intref0040}Mouse monoclonal anti-V5 tagThermo FisherCat\# R960-25; RRID:[AB_2556564](nif-antibody:AB_2556564){#intref0045}ECL HRP-linked rabbit whole AbGE healthcareCat\# NA934; RRID:[AB_772206](nif-antibody:AB_772206){#intref0050}ECL HRP-linked mouse whole AbGE healthcareCat\# NA931; RRID:[AB_772210](nif-antibody:AB_772210){#intref0055}**Biological Samples**Mice dorsal root gangliaThis paperN/A**Chemicals, Peptides, and Recombinant Proteins**DMEM mediaThermo FisherCat\# 11564446Protease inhibitorsRoche DiagnosticsCat\# 11836170001FBSThermo FisherCat\# 11550356TurboFect reagentThermo FisherCat\# 15325016Mouse LamininBecton DickinsonCat\# 354232NGFPromegaCat\# G5141Poly-L-lysineSigma-AldrichCat\# P9155Cytosine β-D-arabinofuranosideSigma-AldrichCat\# C1768Collagenase type IVWorthingtonCat\# LS004186BradykininTocris BioscienceCar\# 3004RapamycinTocris BioscienceCat\# 1292Quick-change mutagenesis kitAgilent TechnologiesCat\# 200521PBMCFocus BiomoleculesCat\# 10-1413Glutathione-agaroseSigma-AldrichCat\# G4510**Experimental Models: Cell Lines**HEK293TATCCCat\# CRL11268Gα~q~^−/−^ MEF cellsProvided by Prof. Stefan Offermanns[@bib48]**Experimental Models: Organisms/Strains**Gα~q~ knockout miceProvided by Prof. Stefan Offermanns[@bib25]**Recombinant DNA**Rat TRPM8-V5-His[@bib47]N/AG protein alpha qcDNA resource centerCat\# GNA0Q00000Bradykinin receptor B2RcDNA resource centerCat\# BDKB20TN00Histamine receptor H1RcDNA resource centerCat\# HRH010TN006xHis-tag PLCβ1Provided by Prof. Elliott M. Ross (UTSMC)N/AmRFB-FKBP-5-ptaseProvided by Dr. Gerry Hammond (University of Pittsburgh)[@bib37]PM-FRB-CFPProvided by Dr. Gerry Hammond[@bib37]Tubby-R332H-cYFPProvided by Dr. Gerry Hammond[@bib32]GST-pcDNA3[@bib10]N/A**Software and Algorithms**SigmaplotSystat Software Inc.<https://systatsoftware.com/products/sigmaplot/>pClamp11Molecular Device<https://www.moleculardevices.com/products/axon-patch-clamp-system/acquisition-and-analysis-software/pclamp-software-suite>Discovery studio 4.5BIOVIA<https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/>ImageJNIH<https://imagej.nih.gov/ij/>**Other**Axopatch 200B amplifierMolecular Devices<https://www.moleculardevices.com/products/axon-patch-clamp-system/amplifiers/axon-instruments-patch-clamp-amplifiers#gref>Confocal microscopeLeica<https://www.leica-microsystems.com/products/confocal-microscopes/>

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Xuming Zhang (<x.zhang39@aston.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Animals {#sec4.3.1}

Gα~q~^−/−^ mice were kindly provided by Prof. Stefan Offermanns (Max-Planck-Institute, Bad Nauheim, Germany). The male and female mice and their littermates were maintained on a C57BL/6 background housed in a 12h light/dark cycle with food and water *ad libitum.* The experiments on mice were approved by the ethical review committee of Aston University and UK home office and carried out in accordance with the Animal Scientific Procedures Act 1986 in the UK. The knockout mice are viable but exhibit impaired motor coordination and defective platelet activation ([@bib24], [@bib25]).

### DRG neurons and cell lines {#sec4.3.2}

DRG neurons were isolated from male and female wild-type or Gα~q~^−/−^ mice of 2-7 days after birth following sacrifice by cervical dislocation and cultured as described previously ([@bib36], [@bib46]). Briefly, isolated DRGs were treated with type IV collagenase (Worthington, LS004186) followed by trituration. The dissociated DRG neurons were then seeded onto coverslips coated with poly-L-lysine (Sigma, P9155) and laminin (BD, 354232) and maintained in DMEM media (Thermo fisher, 11564446) containing 10% fetal bovine serum (Thermo Fisher, 11550356), 2mM L-glutamine, 100IU/ml penicillin, 100 μg/ml streptomycin supplemented with 5 μM cytosine β-D-arabinofuranoside (Sigma, C1768) and 50ng/ml nerve growth factor (Promega, G5141). The cultured DRG neurons were used within 24 hours after isolation.

HEK293 cell line was purchased from ATCC, and MEF cells derived from Gα~q/11~^−/−^ mice were obtained from Prof. Stefan Offermanns (Max-Planck-Institute, Germany) as described previously ([@bib47]). The cells lines were maintained in high glucose DMEM media containing 10% fetal bovine serum, 100IU/ml penicillin and 100 μg/ml streptomycin at 37°C in a humidified incubator (5% CO2). Cells were used between 15 and 30 passage numbers. The cell lines were derived from embryos and the sex of these cell lines is thus not available.

Method Details {#sec4.4}
--------------

### Cell transfection {#sec4.4.1}

HEK293 and MEF cells were transfected with plasmid cDNAs using TurboFect transfection reagent (Thermo Fisher Scientific, 15325016) as described previously ([@bib10], [@bib47]). Briefly, 4 μg cDNA in 400 μL serum-free media was mixed with 8 μL TurboFect reagent followed by incubation for 20 min at RT. The transfection complexes were then added to the cells and incubated for 24h. For single cell electrophysiology, cells were co-transfected with GFP for identification of successfully transfected cells.

### Molecular Biology {#sec4.4.2}

GST-coupled TRPM8 cytoplasmic fragments were constructed by amplifying relevant N- and C-terminal fragments from rTRPM8 with PCR followed by cloning into the GST-pCDNA3 vector via BamHI and EcoRI ([@bib10]). Truncation of GST-coupled protein fragments was produced by introducing a stop codon at targeted sites using Quick-Change mutagenesis kit (Agilent Technologies, 200521). The kit was also used to generate all the TRPM8 mutants. cNDAs for HA-B2R (BDKB20TN00) and HA-H1R (HRH010TN00) and Gα~q~ (GNA0Q00000) were from the Missouri cDNA resource center. PLCβ-His (6x) cNDA is a kind gift from Dr. Elliott Ross (University of Texas Southwestern Medical Center at Dallas). The membrane lipid PIP~2~ depletion was induced using mRFB-FKBP-5-ptase catalytic domain together with membrane targeted PM-FRB-CFP (kindly provide by Dr. Gerry Hammond, University of Pittsburgh), as described ([@bib37]). All other cDNA constructs including TRPM8-V5-His, Tubby-R332H-YFP and Gα~qi~ chimeras have been described in the previous paper ([@bib47]).

### Pull down assay and western blot {#sec4.4.3}

GST pull down assay was performed as described previously ([@bib10], [@bib47]). Briefly, GST-coupled TRPM8 cytoplasmic fragments expressed from HEK293 cells were isolated using GST-agarose (Sigma, G4510), and then incubated with protein lysate containing Gα~q~ Q209L in a binding buffer (20mM Tris-HCl, pH 7.4, 150mM NaCl, 1% NP-40, 1mM EDTA, 1mM EGTA and protease inhibitor cocktails (Roche, 11836170001)) at 4°C overnight. Bound Gα~q~ proteins were eluted by boiling in sample buffer followed by separation in 10% SDS-PAGE gel and detection with primary anti-Gα~q~ (Santa Cruz, sc-393) and secondary HRP-linked rabbit antibody (GE healthcare, NA934). The blots were stripped and redetected with HRP-conjugated anti-GST (GE healthcare, RPN1236).

Nickel beads pull down assay was conducted as described previously with slight modifications ([@bib47]). Briefly, HEK293 cells expressing TRPM8-V5-His with HA-B2R or with HA-H1R were solubilized in lysis buffer (20mM Tris-HCl, pH7.4, 300mM NaCl, 1% NP-40, 10% glycerol, 0.2mM EDTA, 20mM imidazole plus protease inhibitor cocktail). Protein lysates were then incubated with nickel beads (QIAGEN) at 4°C overnight. After thorough washing in lysis buffer, nickel beads were boiled in sample buffer. Eluted proteins were resolved on 7.5% SDS-PAGE gel followed by western blot detection with anti-HA (Covance, 101R-1000) and anti-V5 (Thermo Fisher, R960-25) together with secondary HRP-linked mouse antibody (GE healthcare, NA931). Similar nickel pull down assay was also performed for determination of the effect of TRPM8 on Gα~q~ binding to hexahistidine-tagged PLCβ ([Figure 7](#fig7){ref-type="fig"}E). In this case, HEK293 cell lysate expressing TRPM8 was added to the cell lysate containing PLCβ-his and Gα~q~ Q209L. After incubation at 4°C overnight, the cell lysate mixture was thoroughly washed and bound Gα~q~ protein was then detected with anti-Gα~q~ followed by stripping and redetection with anti-PLCβ (Santa Cruz, sc-9050). All the blots shown are representative of at least three independent experiments.

The expression level of TRPM8, Gα~q~ and Gα~11~ in Gα~q~^−/−^ mice was detected using western blot with anti-TRPM8 (Alomone labs, ACC-049), anti-Gα~q~ (Santa Cruz, sc-393) and anti-Gα~11~ (Santa Cruz, sc-394), respectively. The blots were also stripped and redetected with anti-β-tubulin (Sigma, T4026) for verifying equal loading across samples.

### Electrophysiology {#sec4.4.4}

All electrophysiology recordings were obtained using an Axopatch 200B patch amplifier (Molecular Devices) as described previously ([@bib10], [@bib47]). Briefly, patch pipettes were fabricated from thin-walled glass capillary using a pipette puller (Sutter instrument) with a resistance between 2.5 ∼4.0 MΩ and filled with internal solution (in mM): 140 KCl, 2.0 MgCl2, 5 EGTA. 10 HEPES, pH 7.4 with KOH. Ca^2+^-free extracellular solution was used and contained (in mM): 140 NaCl, 4 KCl, 10 HEPES, 1 MgCl2, 5 EGTA, 5 Glucose, pH7.4 with NaOH. Ca^2+^-containing Hanks solution was largely similar to Ca^2+^-free solution except that 5mM EGTA in Ca^2+^-free solution was replaced with 2mM CaCl~2~. For studying the effect of GPCR and PIP~2~ signaling on TRPM8 in [Figure 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}, cells were pretreated with BK (Tocris, 3004) or histamine or rapamycin (Tocris, 1292) for 1min to allow intact completion of signaling before entering whole-cell configuration. After establishment of whole-cell, series resistance was 80% compensated. Signals were analog filtered at 1 KHz using a low-pass Bessel filter of the amplifier and digitized with Digidata 1440A (Molecular Devices). Recordings were made at RT with a holding potential at −60mV or + 60mV.

The current-voltage (I-V) relationship of TRPM8 was determined using a ramp depolarization from −120mV to +120mV in 650 msec. Voltage-dependent activation of TRPM8 was further investigated from currents evoked by depolarization voltage steps from −120mV up to +200mV in 20mV increments with every step lasting for 100msec.The half-maximal activation voltage (V~1/2~) was calculated using the Boltzmann equation as described previously ([@bib47]).

Cell-attached recordings were performed as described previously ([@bib21], [@bib29], [@bib47]). Patch pipettes were pulled from thick-walled glass tubing with a resistance between 8 ∼12 MΩ and a tight seal with seal resistance over 1GΩ was typical obtained. Cell-attached voltage-clamp mode was then used to measure action potential currents in DRG neurons evoked by different stimuli under normal Ca^2+^-containing Hanks solution (see above). Cell-attached patch clamping maintains the intracellular contents of cells allowing for reliable and long lasting recording of action potentials. As TRPM8 is mainly expressed in small-to-medium sized DRG neurons ([@bib7]), we probed at random the responses of small-to-medium DRG neurons to cold, WS-12 and PBMC (Focus Biomolecules, 10-1413) for identification of TRPM8^+^ neurons. Normal Hanks solution was used for both bath and pipette solutions.

### Fluorescence imaging {#sec4.4.5}

Imaging of Tubby-R332H-YFP in live cells were performed using a Leica confocal microscope (Leica) as described previously ([@bib14], [@bib36], [@bib47]). Fluorescence signals were acquired every 0.75 s. Bradykinin (1 μM) or rapamycin (1 μM) was added to the bath solution during imaging. Membrane PIP~2~ depletion was estimated by quantifying the ratio of fluorescence signals on the membrane to those in the cytosol using ImageJ (NIH).

### Protein structure modeling {#sec4.4.6}

The structure of TRPM8 (PDB: 6BPQ) and Gα~q~ (PDB: 3OHM) was analyzed and modeled using Discovery studio 4.5 (BIOVIA).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Firing events of DRG neurons and TRPM8 currents were quantified and analyzed using the Clampfit 10.2 software (Molecular Devices). The number of cells was denoted in parentheses above the bars of each figure and derived from at least three different days of preparations. All the data passed the normality test and are shown as mean ± SEM. Significance between groups was determined using Student's t test or one-way ANOVA, and considered significant at p \< 0.05.

Supplemental Information {#app2}
========================

Document S1. Figures S1--S4Document S2. Article plus Supplemental Information

I would like to thank Dr. Dan Rathbone for assistance with protein structure modeling and Dr. Gerry Hammond for help with live imaging and analysis. This work was supported by an MRC grant (G0801387) and intramural funding from Aston University. Original data for this work are available through Aston data Explorer at <https://doi.org/10.17036/researchdata.aston.ac.uk.00000427>.

Author Contributions {#sec5}
====================

X.Z. designed and performed experiments, analyzed data, and wrote the paper.

Declaration of Interests {#sec6}
========================

The author declares no competing interests.

Supplemental Information can be found online at <https://doi.org/10.1016/j.celrep.2019.05.080>.

[^1]: Lead Contact
